Fluzone Tiv Sh 2026 Injection, Suspension
Product Images NDC 49281-626

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fluzone Tiv Sh 2026 (NDC 49281-626). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Principal Display Panel (0.5 mL Syringe Label)
Label of Fluzone Southern Hemisphere 2025 Formula influenza vaccine, single-dose 0.5 mL injection suspension. It is preservative-free, for intramuscular use, and manufactured by Sanofi Pasteur Inc. The label includes the NDC 49281-325-88 and space for lot and expiration dates.*
FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

Principal Display Panel (0.5 mL Syringe Carton)
Packaging label for Fluzone Southern Hemisphere Influenza Vaccine, 2025 Formula, for intramuscular use. The carton is labeled for individuals 6 months and older, containing 10 single-dose prefilled syringes of 0.5 mL each. The label shows the NDC 49281-325-50 and the Sanofi Vaccines US Inc. logo. Storage and usage instructions are included.*
FDA Label Image

Principal Display Panel (5 mL Vial Label)

Principal Display Panel (5 mL Vial Label)
Label for Fluzone Influenza Vaccine Southern Hemisphere 2025 Formula, 5 mL multi-dose vial form. It includes storage instructions, dosing for different age groups, and indicates intramuscular use. The label lists Sanofi Pasteur Inc. as the manufacturer and shows the NDC 49281-356-78.*
FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Principal Display Panel (5 mL Vial Carton)
Packaging label for FLUZONE Southern Hemisphere Influenza Vaccine 2025 Formula, 5 mL multi-dose vial for intramuscular injection. The label states it is for ages 6 months and older, with dosing instructions for different age groups. Manufactured by Sanofi, NDC 49281-356-15. Storage instructions and vaccine strain information for the 2025 influenza season are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.